Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients
Clinical trial NCT00469209 · COMPLETED
Trial details
- NCT number
- NCT00469209
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2008-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.